The Foreign Direct Investment Policy (" FDI Policy ") is the primary regulation governing foreign investment in India. The Government of India (" Government ") introduced several amendments to the FDI Policy through the annual Consolidated Foreign ... Gibson Dunn, 3 weeks ago
3 images for "biotechnology regulatory authority of india b"
India is emerging as a target destination for procuring support services required for the global pharmaceutical industry, especially in pharmacovigilance. Several steps have been taken by the Indian regulatory authorities recently to strengthen the ...PharmaBiz, 1 month ago
Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting
HERTFORDSHIRE, England , PITTSBURGH and BENGALURU, India , June 3, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of data from the HERITAGE study at the 2016 ...Barchart, 1 month ago ASCO2016: Mylan-BioCon's Biosimilar Cancer Drug Comparable to Roche's Herceptin BioSpace, 1 month ago
1. GMO foods and crops pose health risks Scientific organisations Stijn Bruers' article starts with an appeal to authority in claiming GMOs are safe, that doesn't stand up to scrutiny. He cites a number of respected scientific organisations, ...Corporate Europe Observatory, 1 week ago
As seen in the latest issue of Master Investor Magazine Investors often suppose that biotechnology is all about the development of new wonder drugs which zap bacteria and viruses pharmacology. But in fact the best investment prospects probably ...Master Investor, 3 weeks ago
Theme: Biotechnology and GMO, Media Disinformation Unlike their predecessors, early 21st century missionaries do not come armed with bibles. They come as members of a scientific priesthood, spouting slick PR and are supported by the likes of Bill ...Global Research, 3 weeks ago
More from: , Counter Currents...and 1 other sources
Biotechnology company Monsanto announced Tuesday that it has refused a $62 billion takeover offer from pharmaceutical giant Bayer AG as "incomplete" and "inadequate." Monsanto has been open to a corporate takeover to help resolve some financial ...Equities.com, 2 months ago
This announcement replaces the announcement released at 3.45 pm yesterday, July 12th, 2016 (RNS Number 9835D) and the revised announcement released at 1.45pm today (RNS Number 0988E). The previous announcements disclosed incorrect Percentage Change ...London South East, 2 weeks ago
While all of that activity was volatile and dramatic, we did not see much change in underlying market trends, which can be best described as an ugly grind higher. Trends were generally positive and stronger for U.S. markets than for International ...Seeking Alpha, 3 weeks ago
/PRNewswire/ -- Forecasts for Insulin Pumps, Enteral Feeding Pumps, Other Infusion Pumps for Insulin Infusion, Drug Delivery, Oncology, Antibiotics, Analgesia, Hydration, Immune Globulin Intravenous, Chelation Therapy and Immune Globulin ...TickerTech.com, 4 weeks ago
More from: , Pharmacy Choice...and 5 other sources
on your WebpageAdd Widget >Get your members hooked!